Xenex Stock
Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.
Sign up today and learn more about Xenex Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Xenex Stock
Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.
Funding History
September 2012 | $9.2M |
---|---|
November 2013 | $11.3M |
January 2015 | $25.0M |
September 2016 | $3.0M |
February 2017 | $38.0M |
October 2018 | $5.0M |
Management
CEO
Morris Miller
Co-Founder
Brian Cruver
Co-Founder, Chief Scientific Officer & Speaker
Mark Stibich
Co- Founder & Chief Epidemiologist
Julie Stachowiak
Vice President of Sales & Account Management
Irene Hahn
Senior Vice President Global Sales
Joseph Authement
Vice President of Supply Chain & Manufacturing
Rodger Mack
Chief Operating Officer & Chief Financial Officer
Paul Froutan
Chief Technical Advisor
Paul Froutan
Press
globenewswire - Jan, 4 2024
Safe and Green Development Corporation Announces Update on LOI for Acquisition of Xene Real Estate AI Softwarebizjournals - Sep, 7 2023
SA germ-zapping robot-maker Xenex clears major FDA hurdle - San Antonio Business Journaldlvr - Mar, 24 2023
Corsair Xeneon 27 QHD240 OLED gaming monitorbizjournals - Oct, 1 2021
Xenex CEO in race to build faster, smarter robots to combat next global threattrib - Dec, 30 2020
San Antonio tech grew in '20, poised for more expansion in '21